Fresenius Steps Up International Ambition Through Akorn Pursuit
German healthcare company Fresenius SE & Co. pursues a second major international deal in less than year, as new CEO confirms interest in US generics firm Akorn.
German healthcare company Fresenius SE & Co. pursues a second major international deal in less than year, as new CEO confirms interest in US generics firm Akorn.